On 20 March 2013, BIO Deutschland attended the meeting of the National Associations Council (NAC) and the Healthcare Council (HC) in Brussels. Peter Heinrich represented the association at the board meeting.
The 13th meeting of the Working Group on Diagnostics was held in Berlin on 8 March 2013. The agenda included discussion on the European Commission’s proposal for a regulation on in vitro diagnostic medical devices and on the individual health services that German doctors and psychotherapists can offer their patients with statutory health insurance on a private-patient basis.
Around 80 finance experts from the biotech scene recently discussed the current financing situation for innovations in Germany at the seventh biotech finance meeting, which was organised by BIO Deutschland and took place in Berlin. Finance was up by over 50 per cent in 2012 compared with the previous year, from some €142 million in 2011 to €300 million in 2012.
